vialroom

#asia 2026-04-18

Saturday13 messages4 participantstimes are UTC
Highlights from this day
  • hydrate_hana — india has a real generics manufacturing base and a real domestic market. what a specific product is, and whether it matches its label, is a separate question every… 19:41
  • hydrate_hana — the honest position on india is that i have seen good material and bad material and the paperwork told me nothing either way 19:56
  • hydrate_hana — being closer to the manufacturing does not shorten customs. my parcels from three hours away took as long as ones from europe, happy to be corrected 20:11
  • hydrate_hana — japan being expensive despite the approval is the pattern. approval sets the licence and the pricing system sets the price, ill dig out the number 21:07

india has a real generics manufacturing base and a real domestic market. what a specific product is, and whether it matches its label, is a separate question every single time

📈139
SS

sourcing is physically closer here, why is it not simpler

HH

the honest position on india is that i have seen good material and bad material and the paperwork told me nothing either way

korea is fast

japan approved it

write it down for the pharmacy

HH

being closer to the manufacturing does not shorten customs. my parcels from three hours away took as long as ones from europe, happy to be corrected

HH

japan being expensive despite the approval is the pattern. approval sets the licence and the pricing system sets the price, ill dig out the number

MM

a member in tokyo reported an out of pocket cost in the region of twenty thousand yen a month in 2024, at a clinic